Table 2.
Etiological examination results.
| Etiological examination | Results | Reference value |
|---|---|---|
| COVID-19 DNA | – | – |
| CMV DNA | – | – |
| EBV antibody | ||
| Ig A &Ig M | – | – |
| Ig G | + | – |
| Mpn IgM | – | – |
| Cpn IgM | – | – |
| Lpn IgM | – | – |
| Rickettsia IgM | – | – |
| INFA&INFB IgM | – | – |
| RSV IgM | – | – |
| PIV IgM | – | – |
| ADV IgM | – | – |
| Sputum culture | – | – |
| Sputum smear for AFB | – | – |
| BALF mNGS | Dialister pneumosintes (46*) | |
| Dialister invisus (36*) |
–, negative; +, positive; COVID-2019, Corona Virus Disease-2019; CMV, Cytomegalovirus; EBV, Epstein-Barr virus; Mpn, Mycoplasma pneumonia; Cpn, Chlamydia pneumonia; Lpn, Legionella pneumophila; INFA, Influenza A Virus; INFB, Influenza A Virus; RSV, Respiratory syncytial virus; PIV, Parainfluenza virus; ADV, Adenovirus; AFB, acid-fast bacillus; BALF, Bronchoalveolar lavage fluid; mNGS, Metagenomic next-generation sequencing.
*
The number of mNGS squences.